Evidence map

ArticleDiabetes, obesity & metabolism2022

A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide.

Lai San Tham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34697882